CAMRF (Camurus AB) Institutional Ownership: 20.10% (As of Jul. 01, 2026)


CAMRF Camurus AB CAMRF
83 GF Score
Price $61.01
GF Value $83.63
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Camurus AB Institutional Ownership?

Camurus AB CAMRF 83 Institutional Ownership is 20.10% as of Jul. 01, 2026. GuruFocus rates CAMRF with a GF Score™ of 83/100 and a GF Value™ of $83.63 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Camurus AB's institutional ownership is 20.10%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Camurus AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Camurus AB's Float Percentage Of Total Shares Outstanding is 0.00%.

Camurus AB Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Camurus AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Camurus AB Institutional Ownership Chart

Camurus AB Historical Data

The historical data trend for Camurus AB can be seen below:

2025-08-31 2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31
Institutional Ownership 28.52 29.10 28.39 29.62 29.31 29.51 28.96 28.54 28.58 28.81
CAMRF
83GF Score
Camurus AB CAMRF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Camurus AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 20.10% mean?
Camurus AB (CAMRF) has a Institutional Ownership of 20.10% as of Jul. 01, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Camurus AB and its competitors.
Is Camurus AB's Institutional Ownership too high?
Camurus AB's current Institutional Ownership is 20.10%. Overall, Camurus AB has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Camurus AB's Institutional Ownership compare to VRTX and REGN?
Camurus AB's Institutional Ownership of 20.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Camurus AB and its competitors. Camurus AB's current Institutional Ownership is 20.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Camurus AB stock overvalued right now?
Based on GuruFocus' analysis, Camurus AB (CAMRF) is currently considered Modestly Undervalued. The stock's GF Value™ is $83.63, compared to a current price of $61.01 — trading 27% below its estimated fair value. The current Institutional Ownership is 20.10%. Camurus AB's overall GF Score™ is 83/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Camurus AB (CAMRF), the current Institutional Ownership is 20.10% as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Camurus AB (CAMRF) Overvalued in 2026?

Based on GuruFocus' analysis, Camurus AB stock appears to be undervalued. The current stock price of $61.01 is trading 27% below its estimated GF Value™ of $83.63. GuruFocus considers Camurus AB to be Modestly Undervalued.

Key valuation signals for CAMRF:

  • Institutional Ownership: 20.10%
  • GF Value™: $83.63 vs. price of $61.01 (27% below fair value)
  • GF Score™: 83/100 with 1 warning sign

No single metric tells the full story. See the CAMRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Camurus AB Business Description

Address Rydbergs torg 4, Lund, SWE, SE-224 84
Camurus AB is a science-led biopharmaceutical company focused on developing and commercializing long-acting medicines for the treatment of severe and chronic diseases. It has two approved products, including treatments for opioid dependence, and a development pipeline supported by its FluidCrystal technology. Its clinical pipeline includes product candidates for conditions such as pain, cancer, endocrine, and metabolic diseases, developed in-house and in collaboration with international pharmaceutical companies. Its pipeline programs include CAM2029 for acromegaly, gastroenteropancreatic neuroendocrine tumors, and polycystic liver disease; CAM2038 for chronic pain; CAM4072 for genetic obesity disorders; CAM2043 for Raynaud's phenomenon; CAM4071 for endocrine disorders, among others.
83GF Score

Get the complete analysis for CAMRF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$61.01
Price
$83.63
GF Value